Drug Shortage Report for TOPOTECAN INJECTION
Report ID | 121070 |
Drug Identification Number | 02390981 |
Brand name | TOPOTECAN INJECTION |
Common or Proper name | TOPOTECAN INJECTION |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TOPOTECAN |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 LIVI CA |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2020-07-17 |
Estimated end date | 2020-08-21 |
Actual end date | 2020-08-21 |
Shortage status | Resolved |
Updated date | 2020-08-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-08-26 | French | Compare |
v5 | 2020-08-26 | French | Compare |
v3 | 2020-08-26 | English | Compare |
v2 | 2020-07-24 | French | Compare |
v1 | 2020-07-24 | English | Compare |
Showing 1 to 5 of 5